EMA — authorised 2 February 2018
- Marketing authorisation holder: KYOWA KIRIN LIMITED
- Status: approved
🇪🇺 Crysvita in European Union
EMA authorised Crysvita on 2 February 2018
Marketing authorisation
Crysvita in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in European Union
Frequently asked questions
Is Crysvita approved in European Union?
Yes. EMA authorised it on 2 February 2018.
Who is the marketing authorisation holder for Crysvita in European Union?
KYOWA KIRIN LIMITED holds the EU marketing authorisation.